Roche Proposes 2021 Dividend Increase
February 03 2022 - 2:04AM
Dow Jones News
By Sarah Sloat
Swiss pharmaceutical company Roche Holding AG said Thursday that
it would raise its dividend for 2021 after an increase in sales and
operating profit.
Roche will raise its 2021 dividend by 2% to 9.30 Swiss francs
($10.12). For 2022, it expects the dividend to rise further.
Net income in 2021 was CHF14.9 billion, down from CHF15.1
billion, while core operating profit rose to CHF21.9 bllion for
CHF21.5 billion. Sales grew to CHF62.8 billion from CHF58.3
billion, with sales up in the pharmaceutical and diagnostics
divisions.
Roche expects 2022 sales to be stable or grow in the low-single
digits, while core earnings per share should grow in the low- to
mid-single digit range at constant exchange rates.
The company expects 2022 sales of Covid-19 medicines and
diagnostics to decline by approximately CHF2 billion to around CHF5
billion, and sees sales losses to biosimilars of about CHF2.5
billion. Excluding those effects, Roche expects group sales to grow
in the high-single digit range.
Write to Sarah Sloat at sarah.sloat@wsj.com
(END) Dow Jones Newswires
February 03, 2022 01:49 ET (06:49 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
